Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Adapting Care for Pediatric Patients & Parents During the Pandemic: Q&A with Sangeeta Sule, MD, PhD

Susan Bernstein  |  May 1, 2020

Social distancing and telemedicine are creating unique challenges for pediatric rheumatologists to care for their patients—many of whom are 5 years old or younger. Sangeeta Sule, MD, PhD, discusses how her clinic is adapting…

Filed under:Conditions

Fear & Hope in the Era of the Modern Plague

Jose U. Scher, MD  |  April 29, 2020

This plague has affected each one of us, our families and friends, and abruptly, it has altered the way we relate to one another.

Filed under:OpinionSpeak Out Rheum Tagged with:COVID-19

3 U.S. Children with COVID-19 Have Rare Inflammatory Syndrome

Julie Steenhuysen  |  April 29, 2020

CHICAGO (Reuters)—Three U.S. children infected with the coronavirus are being treated for a rare inflammatory syndrome that appears similar to one that has raised concerns by doctors in Britain, Italy and Spain, a specialist treating the patients told Reuters. All three—who range in age from 6 months to 8 years—have undergone treatment at Columbia University…

Filed under:ConditionsPediatric Conditions Tagged with:coronavirusCOVID-19heartKawasaki diseasePediatric

Trial of Gilead’s Potential Coronavirus Treatment Running Ahead of Schedule

Deena Beasley  |  April 27, 2020

(Reuters)—A key U.S. government trial of Gilead Sciences Inc.’s experimental coronavirus treatment may yield results as early as mid-May, according to the study’s lead investigator, after doctors clamored to enroll their patients in the study. Preliminary findings from the randomized trial of the antiviral drug remdesivir, begun in February by the National Institute of Allergy…

Filed under:Drug Updates Tagged with:coronavirusCOVID-19Gileadremdesivir

U.S. FDA Warns Against Using Hydroxychloroquine for COVID-19

Reuters Staff  |  April 27, 2020

(Reuters)—On April, the U.S. Food and Drug Administration (FDA) cautioned against the use of malaria drug hydroxychloroquine (HCQ) in COVID-19 patients even as President Donald Trump, who has touted it as a “game changer,” advocated for an additional review. The drug, first approved in 1955, provided no benefit and potentially higher risk of death for…

Filed under:Drug Updates Tagged with:coronavirusCOVID-19FDAHydroxychloroquine (HCQ)U.S. Food and Drug Administration (FDA)

The author in her home office.

On Pandemics & Uncertainty: One Rheumatologist’s Story

Belinda Birnbaum, MD  |  April 24, 2020

As the mystery solvers, we are supposed to be comfortable with the unknown, but how does that translate when COVID-19 hits home? A rheumatologist contracts COVID-19.

Filed under:ConditionsOpinionSpeak Out Rheum Tagged with:BirnbaumCOVID-19

Local Depletion of Resident Memory T Cells May Reduce Site-Specific Joint Flares

Carina Stanton  |  April 21, 2020

A study found resident memory T cells may mediate inflammatory arthritis and trigger flares in specific joints, suggesting local depletion of these cells could be a therapeutic strategy…

Filed under:ConditionsRheumatoid Arthritis Tagged with:2019 ACR/ARP Annual MeetingFlaresjointjuvenile idiopathic arthritis (JIA)Rheumatoid Arthritis (RA)

In Memoriam: Luis R. Espinoza, MD: July 3, 1943–March 29, 2020

Joan M. Von Feldt, MD, MSEd, & Graciela S. Alarcón, MD, MPH, MACR  |  April 20, 2020

Surrounded by his immediate family, Luis R. Espinoza, MD, died on March 29 after a prolonged illness.

Filed under:Professional TopicsProfiles Tagged with:EspinozaLuis Espinozaobituary

FDA Considers Tanezumab Application for Chronic OA Pain

Michele B. Kaufman, PharmD, BCGP  |  April 20, 2020

The FDA is considering an application for subcutaneous tanezumab, a monoclonal antibody, as a treatment for moderate to severe osteoarthritis…

Filed under:AnalgesicsConditionsDrug UpdatesPain Syndromes Tagged with:Chronic painFDAosteoarthritis (OA)PainPain ManagementtanezumabU.S. Food and Drug Administration (FDA)

Upper Limb Exercise May Improve Quality of Life for Lupus Patients

Lara C. Pullen, PhD  |  April 20, 2020

A recent study found SLE patients may improve their daily physical function, pain and overall quality of life by adding upper limb exercises to stable treatment regimens and routine care…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:disabilityExerciseExercise/physical therapyhandsystemic lupus erythematosus (SLE)

  • « Previous Page
  • 1
  • …
  • 99
  • 100
  • 101
  • 102
  • 103
  • …
  • 323
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences